Table 2.
Characteristics | Intervention (n = 25) |
Control (n = 25) |
p value for between-group difference |
---|---|---|---|
Age (years) | |||
Mean (SD) | 56.4 (12.9) | 59.1 (10.2) | 0.41 |
Median (range) | 58.0 (28.0–75.0) | 60.0 (34.0–75.0) | |
Sex, n (%) | 0.77 | ||
Male | 16 (64.0%) | 17 (68.0%) | |
Female | 9 (36.0%) | 8 (32.0%) | |
Education received (years), n (%) | 0.27 | ||
≤6 | 0 (0.0%) | 1 (4.0%) | |
6–9 | 24 (96.0%) | 19 (76.0%) | |
>9 | 1 (4.0%) | 5 (20.0%) | |
Stroke type, n (%) | 0.77 | ||
Ischaemic | 17 (68.0%) | 16 (64.0%) | |
Haemorrhagic | 8 (32.0%) | 9 (36.0%) | |
Time since stroke onset at baseline (days) | |||
Mean (SD) | 36.1 (24.2) | 46.0 (74.2) | 0.53 |
Median (range) | 34.0 (7.0–107.0) | 19.0 (5.0–357.0) | |
Stroke-affected side, n (%) | >0.99 | ||
Left | 13 (52.0%) | 13 (52.0%) | |
Right | 12 (48.0%) | 12 (48.0%) | |
Dominant hand, n (%) | 0.35 | ||
Left | 1 (4.0%) | 4 (16.0%) | |
Right | 24 (96.0%) | 21 (84.0%) | |
Brunnstrom stage of stroke recovery for the affected arm, n (%) | 0.69 | ||
Stage 3 | 14 (56.0%) | 11 (44.0%) | |
Stage 4 | 6 (24.0%) | 8 (32.0%) | |
Stage 5 | 5 (20.0%) | 6 (24.0%) | |
Comorbidities, n (%) | |||
Hypertension | 20 (80.0%) | 21 (84.0%) | >0.99 |
Diabetes | 13 (52.0%) | 1 (4.0%) | <0.001 |
Hyperlipidaemia | 5 (20.0%) | 5 (20.0%) | >0.99 |
Vascular disease | 4 (16.0%) | 5 (20.0%) | >0.99 |
Heart disease | 4 (16.0%) | 4 (16.0%) | >0.99 |
Musculoskeletal disorder | 1 (4.0%) | 1 (4.0%) | >0.99 |
No comorbidities | 0 (0.0%) | 1 (4.0%) | >0.99 |
Conventional therapeutic modalities, n (%) | |||
Physical therapy | 25 (100.0%) | 23 (92.0%) | 0.49 |
Functional electric stimulation | 25 (100.0%) | 23 (92.0%) | 0.49 |
Occupational therapy | 25 (100.0%) | 21 (84.0%) | 0.11 |
Aerobic exercises | 23 (92.0%) | 21 (84.0%) | 0.67 |
Acupuncture | 23 (92.0%) | 21 (84.0%) | 0.67 |
Soft robotic glove-assisted hand training | 16 (64.0%) | 10 (40.0%) | 0.09 |
Intermittent pneumatic compression therapy for lower extremity | 6 (24.0%) | 5 (20.0%) | 0.73 |
Facial massage | 3 (12.0%) | 5 (20.0%) | 0.70 |
Speech therapy | 2 (8.0%) | 2 (8.0%) | >0.99 |
Transcranial magnetic stimulation | 1 (4.0%) | 3 (12.0%) | 0.61 |
Equipment-assisted standing training | 2 (8.0%) | 1 (4.0%) | >0.99 |
Experience of using a computer, n (%) | 0.19 | ||
Never | 17 (68.0%) | 19 (76.0%) | |
Rarely | 2 (8.0%) | 5 (20.0%) | |
Sometimes | 3 (12.0%) | 0 (0.0%) | |
Often | 3 (12.0%) | 1 (4.0%) | |
Always | 0 (0.0%) | 0 (0.0%) | |
Experience of using VR, n (%) | >0.99 | ||
Never | 24 (96.0%) | 24 (96.0%) | |
Rarely | 1 (4.0%) | 1 (4.0%) | |
Sometimes | 0 (0.0%) | 0 (0.0%) | |
Often | 0 (0.0%) | 0 (0.0%) | |
Always | 0 (0.0%) | 0 (0.0%) | |
Total duration of VR exercises/game playing (minutes) a | |||
Mean (SD) | 296.04 (132.97) | 267.40 (162.56) | 0.50 |
Median | 350.0 | 350.0 | |
Range | 35.0–420.0 | 35.0–420.0 |
One intervention participant did not receive virtual reality exercises because the participant withdrew from the study immediately after enrolment.
SD, standard deviation; VR, virtual reality.